Halozyme Therapeutics, Inc. (HALO)
63.75
+0.67
(+1.06%)
USD |
NASDAQ |
Apr 07, 12:20
Halozyme Therapeutics Price : 63.75 for April 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Skye Bioscience, Inc. | 0.692 |
| Johnson & Johnson | 238.08 |
| Eli Lilly & Co. | 927.95 |
| Stryker Corp. | 331.16 |
| Glaukos Corp. | 116.38 |
Price Related Metrics
| PE Ratio | 25.02 |
| PS Ratio | 5.478 |
| Price to Book Value | 150.76 |
| Price to Free Cash Flow | 11.87 |
| Earnings Yield | 4.00% |
| Market Cap | 7.524B |
| Operating PE Ratio | 9.373 |
| Normalized PE Ratio | 13.58 |